UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060803
Receipt number R000069563
Scientific Title Effects of collagen peptide-containing micronutrient supplementation on biochemical indices in hemodialysis patients.
Date of disclosure of the study information 2026/03/04
Last modified on 2026/03/05 09:29:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of nutritional supplement drink intake on biochemical indicators in dialysis patients.

Acronym

The effects of nutritional supplements on dialysis patients.

Scientific Title

Effects of collagen peptide-containing micronutrient supplementation on biochemical indices in hemodialysis patients.

Scientific Title:Acronym

Effects of nutritional supplement drink intake on biochemical indicators in hemodialysis patients.

Region

Japan


Condition

Condition

Chronic kidney disease (Hemodialysis patients)

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Hemodialysis therapy, due to its therapeutic characteristics, has been noted to potentially remove not only accumulated uremic toxins and excess fluid from the body, but also trace nutrients and vitamins essential for maintaining biological homeostasis. Deficiencies in these nutrients are implicated in impairing the maintenance of normal biological functions and have been suggested to be associated with worsened prognosis.
This study therefore investigates the actual state of nutrient loss associated with dialysis treatment, the effects of supplementation, and its safety by administering a nutritional supplement beverage containing protein, vitamins, and tracing elements to hemodialysis patients and examining changes in biochemical indicators.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood biochemistry test values before and after intervention.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of nutritional supplement drink.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients undergoing maintenance hemodialysis with a nutritional status of moderate or better.
2) Patients with no problems in eating or swallowing function who can independently consume the test food.
3) Patients who understand the explanation given by the person in charge regarding participation in this study and are able to obtain consent to participate in this study of their own volition.

Key exclusion criteria

1) Patients for whom obtaining their own expression of intent and consent regarding participation in this study are difficult.
2) Patients with blood test results showing serum albumin levels below 3.0 g/dL.
3) Patients for whom discontinuing consumption of foods that could potentially affect fluctuations in protein and micronutrients due to ingestion of the test food is difficult.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Sumihiko
Middle name
Last name Sato

Organization

Medical Corporation Credo Sato Clinic

Division name

Department of Nephrology and Dialysis

Zip code

264-0021

Address

2138-1 Wakamatsucho, Wakaba-Ku, Chiba City, Chiba Prefecture

TEL

043-214-3109

Email

ssato@3109jp.com


Public contact

Name of contact person

1st name Takehiro
Middle name
Last name Okama

Organization

Medical Corporation Credo Sato Clinic

Division name

Department of Medical Technology

Zip code

264-0021

Address

2138-1 Wakamatsucho, Wakaba-Ku, Chiba City, Chiba Prefecture

TEL

043-214-3109

Homepage URL


Email

ookama@3109jp.com


Sponsor or person

Institute

Medical Corporation Credo Sato Clinic

Institute

Department

Personal name



Funding Source

Organization

Nutri Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sato Clinic Institutional Review Board

Address

2138-1 Wakamatsucho, Wakaba-Ku, Chiba City, Chiba Prefecture

Tel

043-214-3109

Email

uchida@3109jp.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2026 Year 02 Month 16 Day

Date of IRB

2026 Year 02 Month 16 Day

Anticipated trial start date

2026 Year 03 Month 06 Day

Last follow-up date

2026 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 03 Month 02 Day

Last modified on

2026 Year 03 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069563